Sep 07, 2022 / 05:20PM GMT
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Well, good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it is my pleasure to host this session with the CooperCompanies.
With us, we have Al White, President and CEO; Kim Duncan, Vice President of Investor Relations and Risk Management. In terms of format, it's going to be a fireside chat. If anybody has a question, please raise your hand, and we will call on you. Al, thanks so much for being here.
Albert G. White - The Cooper Companies, Inc. - President, CEO & Non-Independent Director
Yes, absolutely. Thanks for having me.
Questions and Answers:
Lawrence H. Biegelsen - Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research AnalystOf course. So you guys just reported. Let's start with the fiscal 2023 outlook. You gave some color on the call. You guys just reported Q3 earnings. The Q4 guidance
Trustpilot
